Indikationen
- Beschwerden des unteren Harntrakts aufgrund einer gutartigen Prostatavergrößerung
- Prostatitis
- Prostata-Adenom, Prostatakrebs (Prävention)
- geringe Libido bei Männern
Anwendungsempfehlungen
Standarddosierung: zweimal täglich 50 mgSicherheit
Pygeum-Extrakt hat keine nennenswerten Nebenwirkungen. Es ist unbedenklich, Pygeum-Extrakt über Jahre hinweg einzunehmen. Pygeum-Extrakt kann hervorragend mit anderen Phytotherapeutika und Nährstoffen für die Prostata kombiniert werden.Literatur
1. Nyamai DW et al. Herbal management of benign prostatic hyperplasia. J Cancer Sci Ther. 2016;8(5):130-4.
2. Edgar AD et al. A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS. Neurourol Urodyn. 2007;26(4):458-63.
3. Schleich S et al. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity. Planta Med. 2006;72(9):807-13.
4. Paubert-Braquet M et al. Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. J Lipid Mediat Cell Signal. 1994;9(3):285-90.
5. Papaioannou M et al. The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth. J Cell Mol Med. 2009;13(8B):2210–23.
6. Ishani A et al. Pygeum africanum for benign prostatic hyperplasia: A systematic review and quantitative meta-analysis. Am J Med. 2000;109:654–64.
7. Chatelain C et al. Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study with long-term open label extension. Urology. 1999;54:473-8.
8. Breza J et al. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. Curr Med Res Opin. 1998;14(3):127-39.
9. Coulson S et al. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. Compl Ther Med. 2013;21:172-9.
10. Papaioannou M et al. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth. Invest New Drugs. 2010;28(6):729-43.
11. Komakech R et al. A review of the potential of phytochemicals from Prunus africana (Hook f.) Kalkman stem bark for chemoprevention and chemotherapy of prostate cancer. Evid Based Complement Alternat Med. 2017;2017:3014019.
12. Shenouda NS et al. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine. 2007;31(1):72-81.
13. Hutchison A et al. The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries. Eur Urol. 2007;51(1):207-15.
Comments are closed.